72 Publications (Page 3 of 3)
2007
Effect of celecoxib and novel agent LC-1 in a hamster model of lung cancer.
Vegeler, Reid C⋅Yip Schneider, Michele T⋅Ralstin, Matthew⋅Wu, Huangbing⋅Crooks, Peter A⋅Neelakantan, Sundar⋅Nakshatri, Harikrishna⋅Sweeney, Christopher J and Schmidt, C M
The Journal of surgical research, vol. 143, (no. 1), pp. 169-76, 2007/Nov. | Journal Article
 
Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo.
Yip Schneider, Michele T⋅Wu, Huangbing⋅Ralstin, Matthew⋅Yiannoutsos, Constantin T⋅Crooks, Peter A⋅Neelakantan, Sundar⋅Noble, Stephen⋅Nakshatri, Harikrishna⋅Sweeney, Christopher J and Schmidt, C. M
Molecular cancer therapeutics, vol. 6, (no. 6), pp. 1736-44, 2007/Jun. | Journal Article
2006
Cyclooxygenase-2 Expression in Hamster and Human Pancreatic Neoplasia
Crowell, Pamela L⋅Crowell, Pamela L⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Yip-Schneider, Michele T⋅Yip Schneider, Michele T⋅Savage, Jesse J⋅Savage, Jesse J⋅Hertzler, Dean A⋅Hertzler, Dean A⋅Cummings, William O and Cummings, William O
Neoplasia, vol. 8, (no. 6), pp. 445, June 2006. | Journal Article
 
Cyclooxygenase-2 Expression in Hamster and Human Pancreatic Neoplasia1
Crowell, Pamela L⋅Crowell, Pamela L⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Yip-Schneider, Michele T⋅Yip Schneider, Michele T⋅Savage, Jesse J⋅Savage, Jesse J⋅Hertzler, Dean A⋅Hertzler, Dean A⋅Cummings, William O and Cummings, William O
Neoplasia (New York, N.Y.), vol. 8, (no. 6), pp. 445, 2006-06-01. | Journal Article
 
Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.
Ralstin, Matthew C⋅Gage, Earl A⋅Yip Schneider, Michele T⋅Klein, Patrick J⋅Wiebke, Eric A and Schmidt, C. M
Molecular cancer research : MCR, vol. 4, (no. 6), pp. 387-99, 2006/Jun. | Journal Article
 
Sulindac decreases N-nitrosobis(2-oxypropyl)amine-induced precancerous hepatocellular lesion formation in hamsters
Wentz, Sabrina C⋅Yip Schneider, Michele T⋅Gage, Earl⋅Wang, Yufang⋅Klein, Patrick J⋅Wiebke, Eric A and Schmidt, C. Max
Journal of the American College of Surgeons, vol. 203, (no. 3), pp. S86, 2006. | Journal Article
 
The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer
Klein, PJ⋅Schmidt, C. M⋅Wiesenauer, CA⋅Choi, Jennifer N⋅Gage, Earl A⋅Yip Schneider, Michele T⋅Wiebke, EA⋅Wang, Y.⋅Omer, C. and Sebolt-Leopold, JS
Neoplasia, vol. 8, (no. 1), pp. 1-8, 2006. | Journal Article
 
The Effects of a Novel MEK Inhibitor PD184161 on MEK-ERK Signaling and Growth in Human Liver Cancer1
Klein, Patrick J⋅Klein, Patrick J⋅Schmidt, C. Max⋅Schmidt, C. Max⋅Wiesenauer, Chad A⋅Wiesenauer, Chad A⋅Choi, Jennifer N⋅Choi, Jennifer N⋅Gage, Earl A⋅Gage, Earl A⋅Yip-Schneider, Michele T⋅Yip Schneider, Michele T⋅Wiebke, Eric A⋅Wiebke, Eric A⋅Wang, Yufang⋅Wang, Yufang⋅Omer, Charles⋅Omer, Charles⋅Sebolt-Leopold, Judith S and Sebolt-Leopold, Judith S
Neoplasia (New York, N.Y.), vol. 8, (no. 1), pp. 8, 2006-01-01. | Journal Article
2005
Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.
Yip Schneider, Michele T⋅Nakshatri, Harikrishna⋅Sweeney, Christopher J⋅Marshall, Mark S⋅Wiebke, Eric A and Schmidt, C. M
Molecular cancer therapeutics, vol. 4, (no. 4), pp. 587-94, 2005/Apr. | Journal Article
 
Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-κB pathway in pancreatic carcinoma cells
Yip Schneider, Michele⋅Yip-Schneider, Michele⋅Yip-Schneider, Michele⋅Nakshatri, Harikrishna⋅Nakshatri, Harikrishna⋅Nakshatri, Harikrishna⋅Sweeney, Christopher⋅Sweeney, Christopher⋅Sweeney, Christopher⋅Marshall, Mark⋅Marshall, Mark⋅Marshall, Mark⋅Wiebke, Eric⋅Wiebke, Eric⋅Wiebke, Eric⋅Schmidt, C.⋅Schmidt, C. and Schmidt, C.
Molecular Cancer Therapeutics, vol. 4, (no. 4), pp. 587, 20050401. | Journal Article
2004
Doxorubicin’s effect on MEK activity predicts its chemotherapeutic response in hepatocellular carcinoma
Choi, Jennifer⋅Albertin, Faith⋅Klein, Patrick⋅Wang, Yufang⋅Yip Schneider, Michele⋅Gage, Earl⋅Wiesenauer, Chad⋅Wiebke, Eric A⋅Lillemoe, Keith D and Schmidt, C.Max
Journal of the American College of Surgeons, vol. 199, (no. 3), pp. 80, 2004. | Journal Article
 
Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.
Wiesenauer, Chad A⋅Yip Schneider, Michele T⋅Wang, Yufang and Schmidt, C. M
Journal of the American College of Surgeons, vol. 198, (no. 3), pp. 410-21, 2004/Mar. | Journal Article
 
Multiple anticancer effects of blocking MEK-ERK signaling in hepatocellular carcinoma.sup.1 1 No competing interests declared
Wiesenauer, Chad⋅Yip Schneider, Michele⋅Wang, Yufang and Schmidt, C.Max
Journal of the American College of Surgeons, vol. 198, (no. 3), pp. 410, 20040301. | Journal Article
2003
Inhibition of the phosphatidylinositol 3'-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac.
Yip Schneider, Michele T⋅Wiesenauer, Chad A and Schmidt, C. M
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, vol. 7, (no. 3), pp. 354-63, 2003 Mar-Apr. | Journal Article
 
MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.
Yip Schneider, Michele T and Schmidt, C. M
Pancreas, vol. 27, (no. 4), pp. 337-44, 2003/Nov. | Journal Article
 
Novel combination of a COX-2 inhibitor, NS398, and MEK inhibitor, U0126, in human hepatocellular carcinoma provides synergistic increase in apoptosis
Schmidt, C. Max⋅Wang, Yufang⋅Wiesenauer, Chad⋅Yip Schneider, Michele and Wu, Min
Gastroenterology, vol. 124, (no. 4), pp. A794, 2003. | Journal Article
2002
Cyclo-oxygenase-2 expression in primary cancers of the lung and bladder compared to normal adjacent tissue.
Sweeney, Christopher J⋅Marshall, Mark S⋅Barnard, Darlene S⋅Heilman, Douglas K⋅Billings, Steven D⋅Cheng, Liang⋅Marshall, Steven J and Yip Schneider, Michele T
Cancer Detection and Prevention, vol. 26, (no. 3), pp. 238-44, 2002. | Journal Article
2001
Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells.
Yip Schneider, Michele T⋅Yip-Schneider, Michele⋅Sweeney, C J⋅Sweeney, Christopher⋅Jung, S H⋅Jung, Sin-Ho⋅Crowell, Pamela⋅Crowell, Pamela L⋅Marshall, M S and Marshall, Mark
The Journal of pharmacology and experimental therapeutics, vol. 298, (no. 3), pp. 976-85, 2001/Sep. | Journal Article
 
Pancreatic Tumor Cells with Mutant K-ras Suppress ERK Activity by MEK-Dependent Induction of MAP Kinase Phosphatase-2
Yip-Schneider, Michele T⋅Yip Schneider, Michele T⋅Lin, Amy⋅Lin, Amy⋅Marshall, Mark S and Marshall, Mark S
Biochemical and Biophysical Research Communications, vol. 280, (no. 4), pp. 997, 2001-02-02. | Journal Article
2000
Cyclooxygenase-2 expression in human pancreatic adenocarcinomas.
Yip Schneider, Michele T⋅Barnard, D S⋅Billings, S D⋅Cheng, Liang⋅Heilman, D K⋅Lin, A⋅Marshall, S J⋅Crowell, Pamela L⋅Marshall, M S and Sweeney, Christopher J
Carcinogenesis, vol. 21, (no. 2), pp. 139-46, 2000/Feb. | Journal Article
 
Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association
YIP-SCHNEIDER, Michele T⋅Yip Schneider, Michele T⋅MIAO, Wenyan⋅MIAO, Wenyan⋅LIN, Amy⋅LIN, Amy⋅BARNARD, Darlene S⋅BARNARD, Darlene S⋅TZIVION, Guri⋅TZIVION, Guri⋅MARSHALL, Mark S and Marshall, Mark S
Biochemical Journal, vol. 351, (no. 1), pp. 159, 2000-10-01. | Journal Article
1993
Characterization of interleukin-7-induced changes in tyrosine phosphorylation and c-myc gene expression in normal human T cells.
Yip Schneider, Michele T⋅Horie, M and Broxmeyer, H E
Experimental Hematology, vol. 21, (no. 13), pp. 1648-56, 1993/Dec. | Journal Article